{"id":"NCT05136170","sponsor":"Dompé Farmaceutici S.p.A","briefTitle":"Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease","officialTitle":"4-week,Phase III, Multicenter, Double-masked Clinical Study to Evaluate Safety-efficacy of Cenegermin (Oxervate®) 20 mcg/mL Ophthalmic Solution vs Vehicle in Patients With Severe Sjogren's Dry Eye Treated With Cyclosporine A (PROTEGO-2).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-01-27","primaryCompletion":"2023-05-24","completion":"2023-05-24","firstPosted":"2021-11-29","resultsPosted":"2024-12-04","lastUpdate":"2024-12-04"},"enrollment":85,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye Disease"],"interventions":[{"type":"DRUG","name":"Cenegermin","otherNames":["Oxervate®"]},{"type":"OTHER","name":"Vehicle","otherNames":["Placebo"]}],"arms":[{"label":"Cenegermin","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"Primary Objectives:\n\n* To compare the efficacy of cenegermin vs vehicle in Schirmer I test (without anaesthesia) \\> 10 mm/5 min at Week 4 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in Symptom Assessment in Dry Eye questionnaire (SANDE) global score at Week 12 by testing the superiority.\n\nSecondary Objectives:\n\n* To compare the efficacy of cenegermin vs vehicle in Schirmer I test at Week 4, 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in Cornea and conjunctiva vital staining with fluorescein (National Eye Institute \\[NEI\\] scales) at Week 4, 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in Tear Film Break-Up Time (TFBUT) at Week 4, 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in SANDE scores at Week 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in worsening in symptom scores (SANDE) and/or NEI score at Week 4 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in impact of dry eye on everyday life (IDEEL) questionnaire at Week 4, 8, 12 and 16 by testing the superiority.","primaryOutcome":{"measure":"Number of Patients With Schirmer I Test (Without Anesthesia) >10mm/5min in the Eligible Eye at Week 4","timeFrame":"At Week 4 (Visit 3)","effectByArm":[{"arm":"Cenegermin - FAS","deltaMin":19,"sd":null},{"arm":"Vehicle - FAS","deltaMin":4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States","Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":44},"commonTop":["Eye pain","Eyelid pain","Headache","Eye discharge","Conjunctival hyperaemia"]}}